Therapeutic Nuclear Drug Market Report 2026
Download Free Sample Buy Now
Therapeutic Nuclear Drug Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Therapeutic Nuclear Drug Market Report 2026

Global Outlook – By Type (Radium-223, Lutetium-177, Iodine-131, Other Types), By Distribution Channel (Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes), By Application (Thyroid, Bone Metastasis, Lymphoma, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Therapeutic Nuclear Drug Market Overview

• Therapeutic Nuclear Drug market size has reached to $2.19 billion in 2025

• Expected to grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%

• Growth Driver: Increasing Prevalence Of Cancer Is Driving The Growth Of The Therapeutic Nuclear Drug Market

• Market Trend: Advancements Driving Expansion Of Targeted Radiotherapies

• North America was the largest region in 2025.

What Is Covered Under Therapeutic Nuclear Drug Market?

Therapeutic nuclear drugs refer to a type of medication that uses radioactive materials to target and treat diseases, particularly cancer. These drugs utilize targeted radiopharmaceuticals that bind to cancer cells, delivering a therapeutic dose of radiation directly to these cells to destroy them while minimizing damage to surrounding healthy tissue.

The main types of therapeutic nuclear drug are radium-223, lutetium-177, iodine-131, others. Radium-223 is a type of therapeutic nuclear drug used primarily to treat prostate cancer that has spread to the bones. These are distributed through various distribution channels such as hospitals, ambulatory surgical centers, and cancer research institutes, and are used in various applications such as thyroid, bone metastasis, lymphoma, and others.

Therapeutic Nuclear Drug Market Global Report 2026 Market Report bar graph

What Is The Therapeutic Nuclear Drug Market Size and Share 2026?

The therapeutic nuclear drug market size has grown rapidly in recent years. It will grow from $2.19 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing cancer prevalence, early adoption of iodine-131 in thyroid disorders, limited availability of targeted oncology therapies, growth of nuclear medicine departments, rising clinical acceptance of radiopharmaceuticals.

What Is The Therapeutic Nuclear Drug Market Growth Forecast?

The therapeutic nuclear drug market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to development of novel therapeutic isotopes, expansion of precision oncology approaches, increasing investment in nuclear medicine infrastructure, growing clinical trials for radioligand therapies, favorable regulatory approvals for targeted nuclear drugs. Major trends in the forecast period include rising adoption of targeted radiopharmaceutical therapies, increasing use of lutetium-177 and alpha-emitting isotopes, growth in cancer-specific nuclear drug applications, expansion of combination therapies with nuclear drugs, strengthening focus on safety dosimetry and regulatory compliance.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Therapeutic Nuclear Drug Market Segmentation

1) By Type: Radium-223, Lutetium-177, Iodine-131, Other Types

2) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes

3) By Application: Thyroid, Bone Metastasis, Lymphoma, Other Applications

What Is The Driver Of The Therapeutic Nuclear Drug Market?

The increasing prevalence of cancer is expected to propel the growth of the therapeutic nuclear drug market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells. The prevalence of cancer is due to improved detection and diagnosis, lifestyle factors, environmental exposures, and genetic factors. Therapeutic nuclear drugs act as a valuable component in the arsenal against cancer, providing targeted and effective treatment options for patients by reducing tumor size, alleviating symptoms, and improving quality of life. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, It is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the therapeutic nuclear drug industry.

Key Players In The Global Therapeutic Nuclear Drug Market

Major companies operating in the therapeutic nuclear drug market are Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals

Global Therapeutic Nuclear Drug Market Trends and Insights

Major companies operating in the therapeutic nuclear drug market are advancing targeted radiotherapies by showcasing novel multi-tumor treatment potential through emerging clinical data. These efforts aim to strengthen innovation pipelines, expand therapeutic applications, and accelerate adoption of next-generation radiopharmaceuticals. For instance, in 2025, Actinium Pharmaceuticals, a US-based clinical-stage biopharmaceutical company, launched a new data for ATNM-400, its first-in-class Actinium-225 radiotherapy, demonstrating multi-tumor potential including in non-small cell lung cancer (NSCLC). The findings were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. ATNM-400 is designed to deliver highly potent alpha-particle therapy with precision targeting, supporting its potential as a transformative therapeutic platform across multiple solid tumors. This advancement highlights the industry’s focus on expanding clinical applications of actinium-based radiotherapies to improve patient outcomes and broaden market opportunities.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Therapeutic Nuclear Drug Market?

In May 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired QSAM Biosciences for an undisclosed amount. Through this acquisition, Telix Pharmaceuticals aims to enhance its therapeutic pipeline with the investigational drug Samarium-153-DOTMP, which targets bone metastases and osteosarcoma. QSAM Biosciences is a US-based biotechnology company focused on developing next-generation nuclear therapeutic medicines.

Regional Insights

North America was the largest region in the therapeutic nuclear drug market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Therapeutic Nuclear Drug Market?

The therapeutic nuclear drug market consists of sales of yttrium-90, actinium-225, bismuth-213, therapeutic iodine-123, and copper-67. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Therapeutic Nuclear Drug Market Report 2026?

The therapeutic nuclear drug market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic nuclear drug industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Therapeutic Nuclear Drug Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.51 billion
Revenue Forecast In 2035 $4.27 billion
Growth Rate CAGR of 14.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Distribution Channel, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical G
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Therapeutic Nuclear Drug Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Therapeutic Nuclear Drug Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Therapeutic Nuclear Drug Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Therapeutic Nuclear Drug Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Radiopharmaceutical Therapies

4.2.2 Increasing Use Of Lutetium-177 And Alpha-Emitting Isotopes

4.2.3 Growth In Cancer-Specific Nuclear Drug Applications

4.2.4 Expansion Of Combination Therapies With Nuclear Drugs

4.2.5 Strengthening Focus On Safety, Dosimetry, And Regulatory Compliance

5. Therapeutic Nuclear Drug Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Treatment Centers

5.3 Ambulatory Surgical Centers (Ascs)

5.4 Cancer Research Institutes

5.5 Nuclear Medicine Clinics

6. Therapeutic Nuclear Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Therapeutic Nuclear Drug Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Therapeutic Nuclear Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Therapeutic Nuclear Drug Market Size, Comparisons And Growth Rate Analysis

7.3. Global Therapeutic Nuclear Drug Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Therapeutic Nuclear Drug Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Therapeutic Nuclear Drug Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Therapeutic Nuclear Drug Market Segmentation

9.1. Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radium-223, Lutetium-177, Iodine-131, Other Types

9.2. Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes

9.3. Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Thyroid, Bone Metastasis, Lymphoma, Other Applications

10. Therapeutic Nuclear Drug Market Regional And Country Analysis

10.1. Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Therapeutic Nuclear Drug Market

11.1. Asia-Pacific Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Therapeutic Nuclear Drug Market

12.1. China Therapeutic Nuclear Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Therapeutic Nuclear Drug Market

13.1. India Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Therapeutic Nuclear Drug Market

14.1. Japan Therapeutic Nuclear Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Therapeutic Nuclear Drug Market

15.1. Australia Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Therapeutic Nuclear Drug Market

16.1. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Therapeutic Nuclear Drug Market

17.1. South Korea Therapeutic Nuclear Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Therapeutic Nuclear Drug Market

18.1. Taiwan Therapeutic Nuclear Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Therapeutic Nuclear Drug Market

19.1. South East Asia Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Therapeutic Nuclear Drug Market

20.1. Western Europe Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Therapeutic Nuclear Drug Market

21.1. UK Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Therapeutic Nuclear Drug Market

22.1. Germany Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Therapeutic Nuclear Drug Market

23.1. France Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Therapeutic Nuclear Drug Market

24.1. Italy Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Therapeutic Nuclear Drug Market

25.1. Spain Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Therapeutic Nuclear Drug Market

26.1. Eastern Europe Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Therapeutic Nuclear Drug Market

27.1. Russia Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Therapeutic Nuclear Drug Market

28.1. North America Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Therapeutic Nuclear Drug Market

29.1. USA Therapeutic Nuclear Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Therapeutic Nuclear Drug Market

30.1. Canada Therapeutic Nuclear Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Therapeutic Nuclear Drug Market

31.1. South America Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Therapeutic Nuclear Drug Market

32.1. Brazil Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Therapeutic Nuclear Drug Market

33.1. Middle East Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Therapeutic Nuclear Drug Market

34.1. Africa Therapeutic Nuclear Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Therapeutic Nuclear Drug Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Therapeutic Nuclear Drug Market Regulatory and Investment Landscape

36. Therapeutic Nuclear Drug Market Competitive Landscape And Company Profiles

36.1. Therapeutic Nuclear Drug Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Therapeutic Nuclear Drug Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Therapeutic Nuclear Drug Market Company Profiles

36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Ipsen S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Jubilant DraxImage Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Therapeutic Nuclear Drug Market Other Major And Innovative Companies

Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals

38. Global Therapeutic Nuclear Drug Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Therapeutic Nuclear Drug Market

40. Therapeutic Nuclear Drug Market High Potential Countries, Segments and Strategies

40.1 Therapeutic Nuclear Drug Market In 2030 - Countries Offering Most New Opportunities

40.2 Therapeutic Nuclear Drug Market In 2030 - Segments Offering Most New Opportunities

40.3 Therapeutic Nuclear Drug Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Therapeutic Nuclear Drug Market, Overview Of Key Products - Product Examples
  • Table 2: Global Therapeutic Nuclear Drug Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Therapeutic Nuclear Drug Market, Supply Chain Analysis
  • Table 4: Global Therapeutic Nuclear Drug Market, Major Raw Material Providers
  • Table 5: Global Therapeutic Nuclear Drug Market, Major Resource Providers
  • Table 6: Global Therapeutic Nuclear Drug Market, Major Manufacturers (Suppliers)
  • Table 7: Global Therapeutic Nuclear Drug Market, Major Distributors And Channel Partners
  • Table 8: Global Therapeutic Nuclear Drug Market, Key Technologies & Future Trends
  • Table 9: Global Therapeutic Nuclear Drug Market, Major Trends
  • Table 10: Global Therapeutic Nuclear Drug Market, Major End Users
  • Table 11: Global Therapeutic Nuclear Drug Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Therapeutic Nuclear Drug Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Therapeutic Nuclear Drug Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Therapeutic Nuclear Drug Market - TAM, US$ Billion, 2025
  • Table 15: Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Taiwan, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Taiwan, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South East Asia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South East Asia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: UK, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: UK, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Germany, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Germany, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: France, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: France, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Italy, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Italy, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Spain, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Spain, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Russia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Russia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: North America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: North America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: USA, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: USA, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Canada, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Canada, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: South America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: South America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Africa, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Africa, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Global Therapeutic Nuclear Drug Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 93: Global Therapeutic Nuclear Drug Market - Company Scoring Matrix
  • Table 94: Bayer AG Financial Performance
  • Table 95: Novartis International AG Financial Performance
  • Table 96: Siemens Healthineers AG Financial Performance
  • Table 97: Ipsen S.A. Financial Performance
  • Table 98: Jubilant DraxImage Inc. Financial Performance
  • Table 99: Global Therapeutic Nuclear Drug Market, Competitive Benchmarking (In USD Billions)
  • Table 100: Global Therapeutic Nuclear Drug Market, Competitive Dashboard
  • Table 101: Global Therapeutic Nuclear Drug Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 102: Global, Therapeutic Nuclear Drug Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 103: Global, Therapeutic Nuclear Drug Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 104: Global, Therapeutic Nuclear Drug Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Therapeutic Nuclear Drug Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Therapeutic Nuclear Drug Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Therapeutic Nuclear Drug Market, Supply Chain Analysis
  • Figure 4: Global Therapeutic Nuclear Drug Market, Major Raw Material Providers
  • Figure 5: Global Therapeutic Nuclear Drug Market, Major Resource Providers
  • Figure 6: Global Therapeutic Nuclear Drug Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Therapeutic Nuclear Drug Market, Major Distributors And Channel Partners
  • Figure 8: Global Therapeutic Nuclear Drug Market, Key Technologies & Future Trends
  • Figure 9: Global Therapeutic Nuclear Drug Market, Major Trends
  • Figure 10: Global Therapeutic Nuclear Drug Market, Major End Users
  • Figure 11: Global Therapeutic Nuclear Drug Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Therapeutic Nuclear Drug Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Therapeutic Nuclear Drug Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Therapeutic Nuclear Drug Market - TAM, US$ Billion, 2025
  • Figure 15: Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Taiwan, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Taiwan, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South East Asia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South East Asia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: UK, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: UK, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Germany, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Germany, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: France, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: France, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Italy, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Italy, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Spain, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Spain, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Russia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Russia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: North America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: North America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: USA, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: USA, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Canada, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Canada, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: South America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: South America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Africa, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Africa, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Global Therapeutic Nuclear Drug Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 93: Global Therapeutic Nuclear Drug Market - Company Scoring Matrix
  • Figure 94: Bayer AG Financial Performance
  • Figure 95: Novartis International AG Financial Performance
  • Figure 96: Siemens Healthineers AG Financial Performance
  • Figure 97: Ipsen S.A. Financial Performance
  • Figure 98: Jubilant DraxImage Inc. Financial Performance
  • Figure 99: Global Therapeutic Nuclear Drug Market, Competitive Benchmarking (In USD Billions)
  • Figure 100: Global Therapeutic Nuclear Drug Market, Competitive Dashboard
  • Figure 101: Global Therapeutic Nuclear Drug Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 102: Global, Therapeutic Nuclear Drug Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 103: Global, Therapeutic Nuclear Drug Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 104: Global, Therapeutic Nuclear Drug Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Sarcoma Drugs Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy), By Disease Indication (Malignant Bone Tumors, Soft Tissue Sarcomaz), By Distribution Channel (Hospital Pharmacies, R...

Drug Delivery Devices Market Report 2026 - Global Outlook – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Deliv...

Drug Infusion Systems Market Report 2026 - Global Outlook – By Product Type (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Anal...

Thalassemia Drugs Market Report 2026 - Global Outlook – By Type (Alpha Thalassemia Drugs, Beta Thalassemia Drugs), By Treatment Type (Iron Chelation Therapy, Other Treatments), By Distribution Channel (Hospital Pharmacie...

Advanced Drug Delivery Systems Market Report 2026 - Global Outlook – By Type (Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transdermal Drug Delivery Syste...

Drug Discovery Technologies Market Report 2026 - Global Outlook – By Technology (High Throughput Screening, Genomics, Nanotechnology, Bioinformatics, Combinational Chemistry, Pharmacogenomics, Biochips, Bioanalytical Ins...

Multiple Sclerosis Drugs Market Report 2026 - Global Outlook – By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Other Drug Classes), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online S...

Acne Drugs Market Report 2026 - Global Outlook – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Aci, Benzoyl Peroxide, Other Therapeutics), By End ...

Frequently Asked Questions

The Therapeutic Nuclear Drug market was valued at $2.19 billion in 2025, increased to $2.51 billion in 2026, and is projected to reach $4.27 billion by 2030.

The global Therapeutic Nuclear Drug market is expected to grow at a CAGR of 14.3% from 2026 to 2035 to reach $4.27 billion by 2035.

Some Key Players in the Therapeutic Nuclear Drug market Include, Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals .

Major trend in this market includes: Advancements Driving Expansion Of Targeted Radiotherapies. For further insights on this market. request a sample here

North America was the largest region in the therapeutic nuclear drug market in 2025. The regions covered in the therapeutic nuclear drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us